{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:32:15Z","timestamp":1791685935214,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1150755"],"award-info":[{"award-number":["OPP1150755"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.xphs.2023.04.003","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T02:07:36Z","timestamp":1680833256000},"page":"2267-2275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Formulation and Scale-Up of Fast-Dissolving Lumefantrine Nanoparticles for Oral Malaria Therapy"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7261-7742","authenticated-orcid":false,"given":"Madeleine","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6771-6105","authenticated-orcid":false,"given":"Kurt","family":"Ristroph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiankai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santipharp","family":"Panmai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Nagapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2858-0097","authenticated-orcid":false,"given":"Robert K.","family":"Prud'homme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2023.04.003_bib0001","series-title":"World Malaria Report","first-page":"1","year":"2019"},{"key":"10.1016\/j.xphs.2023.04.003_bib0002","unstructured":"Unicef, https:\/\/data.unicef.org\/topic\/child-health\/malaria\/#:~:text=In%202018%2C %20there%20were%20228 ,under%20five%20dies%20of%20malaria"},{"key":"10.1016\/j.xphs.2023.04.003_bib0003","series-title":"Guidelines for the Treatment of Malaria","year":"2015"},{"issue":"5","key":"10.1016\/j.xphs.2023.04.003_bib0004","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0035-9203(00)90082-8","article-title":"Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria","volume":"94","author":"van Vugt","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.xphs.2023.04.003_bib0005","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/AAC.44.3.697-704.2000","article-title":"Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria","volume":"44","author":"Ezzet","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.xphs.2023.04.003_bib0006","first-page":"434","article-title":"The effect of food consumption on lumefantrine bioavailability in African children receiving artemether\u2013lumefantrine crushed or dispersible tablets (Coartem\u00ae) for acute uncomplicated Plasmodium falciparum malaria","volume":"15","author":"Borrmann","year":"2010","journal-title":"Trop Med Int Health"},{"issue":"1","key":"10.1016\/j.xphs.2023.04.003_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-10-51","article-title":"Stability-indicating HPLC-DAD\/UV-ESI\/MS impurity profiling of the anti-malarial drug lumefantrine","volume":"10","author":"Verbeken","year":"2011","journal-title":"Malar J"},{"issue":"11","key":"10.1016\/j.xphs.2023.04.003_bib0008","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1021\/jm800002y","article-title":"Modulating the therapeutic activity of nanoparticle delivered paclitaxel by manipulating the hydrophobicity of prodrug conjugates","volume":"51","author":"Ansell","year":"2008","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.xphs.2023.04.003_bib0009","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1021\/mp5008663","article-title":"Antitubercular nanocarrier combination therapy: formulation strategies and in vitro efficacy for rifampicin and 5Q641","volume":"12","author":"D'Addio","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2023.04.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202101748","article-title":"Targeted antitubercular peptide nanocarriers prepared by flash nanoprecipitation with hydrophobic ion pairing","author":"Ristroph","year":"2022","journal-title":"Adv Mater Technol"},{"key":"10.1016\/j.xphs.2023.04.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120397","article-title":"Highly-loaded protein nanocarriers prepared by Flash NanoPrecipitation with hydrophobic ion pairing","volume":"601","author":"Ristroph","year":"2021","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2023.04.003_bib0012","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1208\/s12248-016-9970-6","article-title":"Where are the nanodrugs? An industry perspective on development of drug products containing nanomaterials","volume":"18","author":"Havel","year":"2016","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2023.04.003_bib0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/pharmaceutics8020017","article-title":"Nanomilling of drugs for bioavailability enhancement: a holistic formulation-process perspective","volume":"8","author":"Li","year":"2016","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.xphs.2023.04.003_bib0014","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1081\/DDC-120030422","article-title":"Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs","volume":"30","author":"Hu","year":"2004","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2023.04.003_bib0015","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/mp0700211","article-title":"Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media","volume":"4","author":"Matteucci","year":"2007","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2023.04.003_bib0016","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/aic.690490905","article-title":"Chemical processing and micromixing in confined impinging jets","volume":"49","author":"Johnson","year":"2003","journal-title":"AlChE J"},{"issue":"10","key":"10.1016\/j.xphs.2023.04.003_bib0017","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1071\/CH03115","article-title":"Flash nanoprecipitation of organic actives and block copolymers using a confined impinging jets mixer","volume":"56","author":"Johnson","year":"2003","journal-title":"Aust J Chem"},{"issue":"2","key":"10.1016\/j.xphs.2023.04.003_bib0018","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/aic.10633","article-title":"CFD predictions for chemical processing in a confined impinging-jets reactor","volume":"52","author":"Liu","year":"2006","journal-title":"AlChE J"},{"issue":"11","key":"10.1016\/j.xphs.2023.04.003_bib0019","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.ces.2007.10.020","article-title":"Mixing in a multi-inlet vortex mixer (MIVM) for flash nano-precipitation","volume":"63","author":"Liu","year":"2008","journal-title":"Chem Eng Sci"},{"issue":"9","key":"10.1016\/j.xphs.2023.04.003_bib0020","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.xphs.2018.05.003","article-title":"Design of a small-scale multi-inlet vortex mixer for scalable nanoparticle production and application to the encapsulation of biologics by inverse flash NanoPrecipitation","volume":"107","author":"Markwalter","year":"2018","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.04.003_bib0021","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1021\/acs.nanolett.7b04674","article-title":"Controlling and predicting nanoparticle formation by block copolymer directed rapid precipitations","volume":"18","author":"Pagels","year":"2018","journal-title":"Nano Lett"},{"issue":"143","key":"10.1016\/j.xphs.2023.04.003_bib0022","first-page":"e58757","article-title":"Flash nanoprecipitation for the encapsulation of hydrophobic and hydrophilic compounds in polymeric nanoparticles","author":"Markwalter","year":"2019","journal-title":"JoVE"},{"key":"10.1016\/j.xphs.2023.04.003_bib0023","first-page":"17","article-title":"Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale","author":"Feng","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/j.xphs.2023.04.003_bib0024","series-title":"Therapeutic Nanocarriers for Enhanced Drug Delivery: from Laboratory-Scale Formulation to Clinical-Scale Production","first-page":"251","author":"Tian","year":"2020"},{"key":"10.1016\/j.xphs.2023.04.003_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.memsci.2017.03.041","article-title":"Ultrafiltration of nanoparticle colloids","volume":"538","author":"Pansare","year":"2017","journal-title":"J Membr Sci"},{"issue":"11","key":"10.1016\/j.xphs.2023.04.003_bib0026","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1039\/C8SM02418A","article-title":"Amorphous nanoparticles by self-assembly: processing for controlled release of hydrophobic molecules","volume":"15","author":"Feng","year":"2019","journal-title":"Soft Matter"},{"key":"10.1016\/j.xphs.2023.04.003_bib0027","series-title":"Manufacturing Moonshot: How Pfizer Makes Its Millions of Covid-19 Vaccine Doses","author":"Sealy","year":"2021"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923001478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923001478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:42:32Z","timestamp":1758361352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923001478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022354923001478"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.04.003","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation and Scale-Up of Fast-Dissolving Lumefantrine Nanoparticles for Oral Malaria Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}